↓ Skip to main content

Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort

Overview of attention for article published in Frontiers in immunology, June 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort
Published in
Frontiers in immunology, June 2022
DOI 10.3389/fimmu.2022.901055
Pubmed ID
Authors

Daniele Mauro, Antonio Ciancio, Claudio Di Vico, Luana Passariello, Gelsomina Rozza, Maria Dora Pasquale, Ilenia Pantano, Carlo Cannistrà, Laura Bucci, Silvia Scriffignano, Flavia Riccio, Martina Patrone, Giuseppe Scalise, Piero Ruscitti, Maria Vittoria Montemurro, Antonio Giordano, Maria Teresa Vietri, Francesco Ciccia

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 16%
Unspecified 3 7%
Lecturer 3 7%
Researcher 3 7%
Student > Ph. D. Student 3 7%
Other 5 11%
Unknown 20 45%
Readers by discipline Count As %
Medicine and Dentistry 5 11%
Unspecified 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Environmental Science 2 5%
Engineering 2 5%
Other 6 14%
Unknown 24 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2022.
All research outputs
#20,170,265
of 25,658,541 outputs
Outputs from Frontiers in immunology
#22,941
of 32,130 outputs
Outputs of similar age
#315,295
of 445,493 outputs
Outputs of similar age from Frontiers in immunology
#1,498
of 1,950 outputs
Altmetric has tracked 25,658,541 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,130 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,493 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,950 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.